We are live on ! Find out more
ATXS

Astria Therapeutics
ATXS

Delisted

ATXS was delisted on the 22nd of January, 2026.

Back to rankings

50 hedge funds and large institutions have $51.5M invested in Astria Therapeutics in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,421% more call options, than puts

Call options by funds: $7.71M | Put options by funds: $306K

575% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 4

120% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 5

107% more capital invested

Capital invested by funds: $24.9M → $51.5M (+$26.6M)

85% more funds holding

Funds holding: 27 → 50 (+23)

1.85% more ownership

Funds ownership: 5.6% → 7.45% (+1.9%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
50
Holders Change
+23
Holders Change %
+85.19%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
11
Reduced
5
Closed
4
Calls
$7.71M
Puts
$306K
Net Calls
+$7.41M
Net Calls Change
+$2.74M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.17M
2
State Street
State Street
Massachusetts
+$1.2M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$735K
4
N
Nuveen
North Carolina
+$643K
5
Northern Trust
Northern Trust
Illinois
+$458K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$184K
2
WVP
Worth Venture Partners
New Jersey
-$148K
3
JP Morgan Chase
JP Morgan Chase
New York
-$38K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$35.9K
5
Victory Capital Management
Victory Capital Management
Texas
-$24K
Name Holding Trade Value Shares
Change 		Change in
Stake
OCM
26
Ovata Capital Management
Hong Kong
$193K +$178K +5,000 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$175K +$161K +4,534 New
Bank of America
28
Bank of America
North Carolina
$158K +$146K +4,113 New
PVI
29
Pura Vida Investments
New York
$119K +$2.39K +67 +2%
Citadel Advisors
30
Citadel Advisors
Florida
$111K +$102K +2,860 New
Millennium Management
31
Millennium Management
New York
$107K +$98.7K +2,771 New
New York State Common Retirement Fund
32
New York State Common Retirement Fund
New York
$106K +$97.9K +2,750 New
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$101K +$93.3K +2,619 New
TRCT
34
Tower Research Capital (TRC)
New York
$98K +$90.4K +2,537 New
Jane Street
35
Jane Street
New York
$88K +$81.1K +2,277 New
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$86K +$73.4K +2,062 New
AIG
37
American International Group
New York
$71K +$65.5K +1,839 New
Morgan Stanley
38
Morgan Stanley
New York
$66K +$60.7K +1,703 New
Barclays
39
Barclays
United Kingdom
$64K +$58.8K +1,652 New
PAM
40
Panagora Asset Management
Massachusetts
$60K +$55K +1,545 New
Deutsche Bank
41
Deutsche Bank
Germany
$53K +$49.3K +1,384 New
JP Morgan Chase
42
JP Morgan Chase
New York
$39K -$38K -1,066 -51%
Legal & General Group
43
Legal & General Group
United Kingdom
$18K +$16.2K +455 New
Citigroup
44
Citigroup
New York
$16K +$14.4K +403 New
BFEC
45
Benjamin F. Edwards & Company
Missouri
$13K – – –
AIP
46
Ameritas Investment Partners
Nebraska
$10K +$9.47K +266 New
DWA
47
Dorsey Wright & Associates
California
$9K +$8.4K +236 New
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$4.35K +$4.03K +113 New
Osaic Holdings
49
Osaic Holdings
Arizona
$4K -$712 -20 -18%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$1K – – –
1
2
3

ATXS Hedge Fund Activity: Q2 2020 in Review

50 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Astria Therapeutics (ATXS) for Q2 2020, worth a combined $51.5M — up 107% from $24.9M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ATXS positions and 4 closed out — a net gain of 23 holders — while 11 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $5.17M. The largest seller was OrbiMed, exiting entirely with an estimated $184K sold.

  • 50 institutional investors held Astria Therapeutics (ATXS) as of Q2 2020, up from 27 in Q1 2020.
  • Funds reported $51.5M of Astria Therapeutics stock for Q2 2020, up 107% quarter-over-quarter.
  • 27 funds opened new Astria Therapeutics positions in Q2 2020 and 4 closed out, a net change of +23 holders.
  • The largest Astria Therapeutics buyer in Q2 2020 was BlackRock, an estimated $5.17M added.
  • The largest Astria Therapeutics seller in Q2 2020 was OrbiMed, an estimated $184K sold.

Based on aggregated 13F filings for Q2 2020.